Breaking News Instant updates and real-time market news.

ADAP

Adaptimmune

$1.01

-0.09 (-8.22%)

, CYRX

Cryoport

$13.86

0.25 (1.84%)

08:02
10/09/19
10/09
08:02
10/09/19
08:02

Adaptimmune, Cryoport announce three-year agreement for cell therapies transport

Adaptimmune Therapeutics (ADAP) and Cryoport (CYRX) announce a 3-year agreement to ensure safe and fully monitored transport of Adaptimmune's cell therapies. Optimizing manufacturing and supply operations and reducing "vein-to-vein" time for patients in clinical trials and ahead of commercialization is a key priority for Adaptimmune. This agreement with Cryoport will contribute to this, alongside other solutions including investment in the latest systems and technology, digitization of the supply chain information, and improved communications with patients and healthcare professionals. This agreement follows a previous relationship between both companies to support research-based shipments. In addition, Cryoport has a strong partnership with Adaptimmune's preferred specialty logistics provider, further enabling seamless customer support and optimal handling of critical shipments.

ADAP

Adaptimmune

$1.01

-0.09 (-8.22%)

CYRX

Cryoport

$13.86

0.25 (1.84%)

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

ADAP Adaptimmune
$1.01

-0.09 (-8.22%)

07/29/19
07/29/19
NO CHANGE

Adaptimmune management to meet with Morgan Stanley
Meeting to be held in Boston, MA on July 29 hosted by Morgan Stanley.
08/01/19
GUGG
08/01/19
DOWNGRADE
GUGG
Neutral
Adaptimmune downgraded to Neutral from Buy at Guggenheim
Guggenheim analyst Michael Schmidt downgraded Adaptimmune to Neutral from Buy.
08/02/19
GUGG
08/02/19
DOWNGRADE
GUGG
Neutral
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim
As previously reported, Guggenheim analyst Michael Schmidt downgraded Adaptimmune to Neutral from Buy as he believes visibility into the opportunity for the company's pipeline remains limited, particularly following discontinuation of the MAGEA10 program, reports of 3 new patient deaths, and resignation of the company's CMO. Additionally, financing needs may be an overhang, said Schmidt. While results to date for MAGE-A4 in synovial sarcoma "look intriguing," its commercial opportunity is small, added Schmidt.
08/02/19
08/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oshkosh (OSK) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying that while he thinks Oshkosh is a better story than some other machinery names given solid execution and the potential for some growth or at least stability from its non- Access segments, he sees more room for negative catalysts than positive due to the deceleration in macro data, a growing view that AWP will be flat-to-down next year, and order and backlog contraction against a tough comp from FY19. 2. Square (SQ) downgraded to Underperform from Outperform at Evercore ISI. 3. Adaptimmune (ADAP) downgraded to Neutral from Buy at Guggenheim with analyst Michael Schmidt saying he believes visibility into the opportunity for the company's pipeline remains limited, particularly following discontinuation of the MAGEA10 program, reports of 3 new patient deaths, and resignation of the company's CMO. 4. Hilton Grand Vacations (HGV) downgraded to Underweight from Neutral at JPMorgan with analyst Brandt Montour saying he expects poor sentiment to weigh on shares until the company's contract sales reaccelerate in a consistent way, which he feels is not likely until 2020. 5. Valaris (VAL) downgraded to Market Perform from Outperform at Wells Fargo with analyst Coleman Sullivan saying he reduced his EBITDA forecasts through 2021 to account for revised rig startup assumptions, more conservative utilization and dayrate assumptions on floaters and revised cost assumptions. Sullivan, who continues to be disappointed by the lack of contracts at rates peers are able to achieve, sees the company's outlook having more inherent risk going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CYRX Cryoport
$13.86

0.25 (1.84%)

10/10/18
RILY
10/10/18
INITIATION
Target $22
RILY
Buy
Cryoport initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Andrew D'Silva started Cryoport with a Buy rating and $22 price target.
07/01/19
NEED
07/01/19
INITIATION
Target $22
NEED
Buy
Cryoport reinstated with a Buy at Needham
Needham analyst Stephen Unger reinstated coverage of Cryoport with a Buy rating and $22 price target. The analyst believes Cryoport will continue to benefit from "strong" secular growth associated with the global commercialization of novel regenerative medicine therapies and related development activities by the biopharmaceutical industry.

TODAY'S FREE FLY STORIES

F

Ford

$9.06

-0.005 (-0.06%)

, GM

General Motors

$36.14

-0.185 (-0.51%)

12:47
10/23/19
10/23
12:47
10/23/19
12:47
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$9.06

-0.005 (-0.06%)

GM

General Motors

$36.14

-0.185 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Hot Stocks
Breaking Hot Stocks news story on Hexo 

Hexo Corp trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

NLY

Annaly Capital

$8.94

0.05 (0.56%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Options
Annaly Capital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

INTC

Intel

$51.83

-0.175 (-0.34%)

, SFTBF

SoftBank

$0.00

(0.00%)

12:44
10/23/19
10/23
12:44
10/23/19
12:44
Periodicals
Intel files suit against SoftBank's Fortress over patents, Reuters says »

Intel (INTC) has filed an…

INTC

Intel

$51.83

-0.175 (-0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 20

    Nov

C

Citi

$72.11

0.03 (0.04%)

12:42
10/23/19
10/23
12:42
10/23/19
12:42
Periodicals
Judge says Citi claim against Czech miner OKD is eligible, Reuters says »

A Czech court determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

ALXN

Alexion

$105.68

6.46 (6.51%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Recommendations
Alexion analyst commentary  »

Piper a buyer of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

SHI

Sinopec Shanghai

$28.18

-0.44 (-1.54%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Upgrade
Sinopec Shanghai rating change  »

Sinopec Shanghai upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
10/23/19
10/23
12:40
10/23/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SFTBF

SoftBank

$0.00

(0.00%)

, WE

We Company

$0.00

(0.00%)

12:38
10/23/19
10/23
12:38
10/23/19
12:38
Periodicals
WeWork's Claure tells staff layoffs are in the works, Reuters says »

Marcelo Claure,…

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

, RHHBY

Roche

$0.00

(0.00%)

12:36
10/23/19
10/23
12:36
10/23/19
12:36
Periodicals
Trump to nominate Stephen Hahn as FDA commissioner, WSJ reports »

President Trump intends…

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$86.51

-0.32 (-0.37%)

GSK

GlaxoSmithKline

$43.27

0.76 (1.79%)

AZN

AstraZeneca

$44.61

0.69 (1.57%)

SNY

Sanofi

$45.54

0.23 (0.51%)

PFE

Pfizer

$36.63

0.19 (0.52%)

MRK

Merck

$82.39

1.09 (1.34%)

LLY

Eli Lilly

$106.97

-3.03 (-2.75%)

JNJ

Johnson & Johnson

$130.13

0.95 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 11

    Nov

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:32
10/23/19
10/23
12:32
10/23/19
12:32
Syndicate
Hexo announces C$70M private placement of convertible debentures »

Hexo Corp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

CRM

Salesforce

$145.02

2.75 (1.93%)

12:30
10/23/19
10/23
12:30
10/23/19
12:30
Options
Heavy delta short term call buyer in Salesforce »

Heavy delta short term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

DYMEF

DionyMed Brands

$0.00

(0.00%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Hot Stocks
DionyMed Brands receives court application seeking to appoint receiver »

DionyMed Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$785.08

-46.605 (-5.60%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Periodicals
Hedgeye sees 30% downside in Chipotle, adds to Best Idea Short List 

Reported by Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BA

Boeing

$340.95

3.5 (1.04%)

, CAT

Caterpillar

$133.30

-0.39 (-0.29%)

12:28
10/23/19
10/23
12:28
10/23/19
12:28
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been a bit…

BA

Boeing

$340.95

3.5 (1.04%)

CAT

Caterpillar

$133.30

-0.39 (-0.29%)

TXN

Texas Instruments

$120.05

-8.56 (-6.66%)

LLY

Eli Lilly

$106.95

-3.05 (-2.77%)

FB

Facebook

$184.57

2.3 (1.26%)

ADI

Analog Devices

$106.03

-4.88 (-4.40%)

MCHP

Microchip

$93.22

-3.09 (-3.21%)

XLNX

Xilinx

$94.81

-1.2 (-1.25%)

NXPI

NXP Semiconductors

$104.12

-3.62 (-3.36%)

TNK

Teekay Tankers

$2.21

0.22 (11.06%)

WGO

Winnebago

$46.96

4.17 (9.75%)

TMO

Thermo Fisher

$296.86

15.97 (5.69%)

SNAP

Snap

$13.22

-0.78 (-5.57%)

REZI

Resideo

$9.06

-6.11 (-40.28%)

LRN

K12

$20.03

-4.81 (-19.36%)

CMG

Chipotle

$784.15

-47.535 (-5.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 07

    Dec

SPLK

Splunk

$117.82

7.41 (6.71%)

12:25
10/23/19
10/23
12:25
10/23/19
12:25
Options
Splunk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$297.03

16.14 (5.75%)

12:23
10/23/19
10/23
12:23
10/23/19
12:23
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/19
10/23
12:17
10/23/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/19
10/23
12:16
10/23/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.60

-0.27 (-1.51%)

12:15
10/23/19
10/23
12:15
10/23/19
12:15
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PYPL

PayPal

$95.85

-1.55 (-1.59%)

, SYF

Synchrony

$34.88

-0.1 (-0.29%)

12:14
10/23/19
10/23
12:14
10/23/19
12:14
Earnings
Fly Intel: What to watch in PayPal earnings report »

PayPal (PYPL) is…

PYPL

PayPal

$95.85

-1.55 (-1.59%)

SYF

Synchrony

$34.88

-0.1 (-0.29%)

V

Visa

$171.35

0.46 (0.27%)

MA

MasterCard

$260.61

-0.69 (-0.26%)

FB

Facebook

$184.50

2.23 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 21

    Nov

F

Ford

$9.04

-0.025 (-0.28%)

12:00
10/23/19
10/23
12:00
10/23/19
12:00
Options
Large pre-earnings calendar spread in Ford ahead of earnings »

Large pre-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TXN

Texas Instruments

$120.29

-8.32 (-6.47%)

11:50
10/23/19
10/23
11:50
10/23/19
11:50
Options
Aggressive post-earnings put seller in Texas Instruments »

Aggressive post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

, FB

Facebook

$185.39

3.12 (1.71%)

11:48
10/23/19
10/23
11:48
10/23/19
11:48
Periodicals
Bitcoin falls amid Zuckerberg testimony on Facebook's Libra, Bloomberg says »

Bloomberg's Claire…

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

FB

Facebook

$185.39

3.12 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

11:47
10/23/19
10/23
11:47
10/23/19
11:47
General news
President Trump says lifting sanctions on Turkey with ceasefire to be permanent »

President Trump announced…

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.